TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours.
Francesca MastropasquaFlaviana MarzanoAlessio VallettiItalia AielloGiuseppe Di TullioAnnalisa MorganoSabino LiuniElena RanieriLuisa GuerriniGiuseppe GasparreElisabetta SbisàGraziano PesoleAntonio MoschettaMariano Francesco CaratozzoloApollonia TulloPublished in: Molecular cancer (2017)
In this paper we provided evidence that TRIM8 and its regulators miR-17-5p and miR-106b-5 participate to a feedback loop controlling cell proliferation through the reciprocal modulation of p53, miR-34a and N-MYC. Our experiments pointed out that this axis is pivotal in defining drug responsiveness of cancers such ccRCC and CRC.